Liu et al. identify NBAS deficiency as an underrecognized cause of immune dysregulation. Patient transcriptomes reveal myeloid-driven type I interferon activation, linking impaired intracellular trafficking to interferonopathy and suggesting therapeutic potential for JAK inhibition.
Chen-Lu Liu, Liang Zhang, Mei-Ping Lu et al.· Journal of human immunity· 0 citations
Combined TNF and JAK inhibition as an effective therapeutic strategy for TBK1 deficiency is supported and cytotoxic lymphocytes are the primary drivers of aberrant cell death through a T cell-myeloid axis dependent on TNF/IFN-γ synergism.
Xu Han, Jialin Dai, Ji-Hong Xiao et al.· Cell Death & Disease· 0 citations
An upregulated interferon signature was revealed, and monocytes were identified as a major cellular source of inflammation in patients with SPENCDI, expanding the genetic and clinical spectrum of ACP5 deficiency.
Shiling Zhong, Shuang-Yue Ma, Y. El Chazli et al.· Arthritis & Rheumatology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.